RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    유전정보 차별금지의 법적문제 - 외국의 규율 동향과 그 시사점을 중심으로 - = Legal and Regulatory Issues in Genetic Information Discrimination - Focusing on Overseas Regulatory Trends and Domestic Implications -

    한글로보기

    https://www.riss.kr/link?id=A103844812

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    With the onset of the Human Genome Project, social concerns about 'genetic information discrimination' have been raised, but the problem has not yet been highlighted in Korea. However, non-medical institutions' genetic testing which is related to disease prevention could be partially allowed under the revised "Bioethics and Safety Act" from June 30, 2016. In the case of one domestic insurance company, DTC genetic testing was provided for the new customer of cancer insurance as a complimentary service, which made the social changes related to the recognition of the genetic testing. At a time when precision medicine is becoming a new standard for medical care, discipline on genetic information discrimination has become a problem that can not be delayed anymore. Article 46 and 67 of the Bioethics Act stipulate the prohibition of discrimination on grounds of genetic information and penalties for its violation. However, these broad principles alone can not solve the problems in specific genetic information utilization areas such as insurance and employment. The United States, Canada, the United Kingdom, and Germany have different regulations that prohibit genetic information based discrimination. In the United States, Genetic Information Non-Discrimination Act takes a form that adds to the existing law about the prohibition of genetic information discrimination. In addition, the range of genetic information includes the results of genetic tests of individuals and their families, including "family history". Canada has recently enacted legislation in 2017, expanding coverage to general transactions of goods or services in addition to insurance and employment. The United Kingdom deals only with 'predictive genetic testing results of individuals'. In the case of insurance, the UK government and Association of British Insurers (ABI) agree to abide by a policy framework ('Concordat') for cooperation that provides that insurers' use of genetic information is transparent, fair and subject to regular reviews; and remain committed to the voluntary Moratorium on insurers' use of predictive genetic test results until 1 November 2019, and a review of the Concordat in 2016. In the case of employment, The ICO's 'Employment Practices Code (2011)' is used as a guideline. In Germany, Human Genetic Examination Act(Gesetz ${\ddot{u}}ber$ genetische Untersuchungen bei Menschen) stipulates a principle ban on the demand for genetic testing and the submission of results in employment and insurance. The evaluation of the effectiveness of regulatory framework, as well as the form and scope of the discipline is different from country to country. In light of this, it would be desirable for the issue of genetic information discrimination in Korea to be addressed based on the review of related regulations, the participation of experts, and the cooperation of stakeholders.
    번역하기

    With the onset of the Human Genome Project, social concerns about 'genetic information discrimination' have been raised, but the problem has not yet been highlighted in Korea. However, non-medical institutions' genetic testing which is related to dise...

    With the onset of the Human Genome Project, social concerns about 'genetic information discrimination' have been raised, but the problem has not yet been highlighted in Korea. However, non-medical institutions' genetic testing which is related to disease prevention could be partially allowed under the revised "Bioethics and Safety Act" from June 30, 2016. In the case of one domestic insurance company, DTC genetic testing was provided for the new customer of cancer insurance as a complimentary service, which made the social changes related to the recognition of the genetic testing. At a time when precision medicine is becoming a new standard for medical care, discipline on genetic information discrimination has become a problem that can not be delayed anymore. Article 46 and 67 of the Bioethics Act stipulate the prohibition of discrimination on grounds of genetic information and penalties for its violation. However, these broad principles alone can not solve the problems in specific genetic information utilization areas such as insurance and employment. The United States, Canada, the United Kingdom, and Germany have different regulations that prohibit genetic information based discrimination. In the United States, Genetic Information Non-Discrimination Act takes a form that adds to the existing law about the prohibition of genetic information discrimination. In addition, the range of genetic information includes the results of genetic tests of individuals and their families, including "family history". Canada has recently enacted legislation in 2017, expanding coverage to general transactions of goods or services in addition to insurance and employment. The United Kingdom deals only with 'predictive genetic testing results of individuals'. In the case of insurance, the UK government and Association of British Insurers (ABI) agree to abide by a policy framework ('Concordat') for cooperation that provides that insurers' use of genetic information is transparent, fair and subject to regular reviews; and remain committed to the voluntary Moratorium on insurers' use of predictive genetic test results until 1 November 2019, and a review of the Concordat in 2016. In the case of employment, The ICO's 'Employment Practices Code (2011)' is used as a guideline. In Germany, Human Genetic Examination Act(Gesetz ${\ddot{u}}ber$ genetische Untersuchungen bei Menschen) stipulates a principle ban on the demand for genetic testing and the submission of results in employment and insurance. The evaluation of the effectiveness of regulatory framework, as well as the form and scope of the discipline is different from country to country. In light of this, it would be desirable for the issue of genetic information discrimination in Korea to be addressed based on the review of related regulations, the participation of experts, and the cooperation of stakeholders.

    더보기

    참고문헌 (Reference)

    1 "전원재판부 92헌바43, 1994. 2. 24"

    2 "미국의 「유전자 정보 차별금지법(GINA; Genetic Information Non- discrimination Act of 2008)」"

    3 "라이나 생명 고객님 DNA 분석해드립니다"

    4 김나경, "독일 유전자검사법의 규율 구조 이해 - 의료 목적 유전자검사의 문제를 중심으로 -" 대한의료법학회 17 (17): 85-124, 2016

    5 석종욱, "독일 유전자 진단법 Das Gendiagnostikgesetz" 한국법제연구원 2010 (2010): 2010

    6 "대한민국 미래 책임질 9대 국가전략 프로젝트 선정"

    7 김지훈, "국내 개인 의뢰 유전자 검사(DTC) 동향" 2017

    8 Anya E. R. Prince, "When Does an Illness Begin: Genetic Discrimination and Disease Manifestation" 2012

    9 Mark A. Rothstein, "Understanding Genetic Discrimination Laws" 2017

    10 "The workplace wellness program scam strikes again: Employers could demand your genetic information"

    1 "전원재판부 92헌바43, 1994. 2. 24"

    2 "미국의 「유전자 정보 차별금지법(GINA; Genetic Information Non- discrimination Act of 2008)」"

    3 "라이나 생명 고객님 DNA 분석해드립니다"

    4 김나경, "독일 유전자검사법의 규율 구조 이해 - 의료 목적 유전자검사의 문제를 중심으로 -" 대한의료법학회 17 (17): 85-124, 2016

    5 석종욱, "독일 유전자 진단법 Das Gendiagnostikgesetz" 한국법제연구원 2010 (2010): 2010

    6 "대한민국 미래 책임질 9대 국가전략 프로젝트 선정"

    7 김지훈, "국내 개인 의뢰 유전자 검사(DTC) 동향" 2017

    8 Anya E. R. Prince, "When Does an Illness Begin: Genetic Discrimination and Disease Manifestation" 2012

    9 Mark A. Rothstein, "Understanding Genetic Discrimination Laws" 2017

    10 "The workplace wellness program scam strikes again: Employers could demand your genetic information"

    11 "The employment practices code"

    12 "Palo Alto DNA-privacy case could have wide implications"

    13 "Opposition grows to ‘workplace wellness’ bill that would scale back genetic privacy"

    14 "INSURANCE, PRIVACY AND THE CONCORDAT AND MORATORIUM"

    15 "House Republicans would let employers demand workers’ genetic test results"

    16 "Genetic Testing Model for CI: If Underwriters of Individual Critical Illness Insurance Had No Access to Known Results of Genetic Tests" Canadian Institute of Actuaries 2016

    17 "Genetic Testing Model for CI: If Underwriters of Individual Critical Illness Insurance Had No Access to Known Results of Genetic Tests" Canadian Institute of Actuaries 2016

    18 "Genetic Information Non-discrimination Act of 2008 (P.L. 110-233, 122 Stat. 881)"

    19 Robert C. Green, "GINA, Genetic Discrimination, and Genomic Medicine" 398-, 2015

    20 "Data Protection Act"

    21 "Concordat and Moratorium on Genetics and Insurance" HM Goverment & Association of British Insurers 2014

    22 "Canada’s new genetic privacy law is causing huge headaches for Justin Trudeau" 2017

    23 "Canada passes genetic non-discrimination bill"

    24 "Bill S-201 - Genetic Non-Discrimination Act (Canada)" Department of Health and Human Services (HHS) 2009

    25 Yann Joly, "A need to redefine privacy in the context of a data intensive health system" 2017

    26 EEOC v. Honeywell Int'l, Inc, "2014WL5795481(D. Minn., November 6, 2014)"

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2022 평가 재인증평가 신청대상 (재인증)
    2019-01-01 등재 등재학술지 유지 (계속평가) KCI등재
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2015-12-01 등재 등재후보로 하락 (기타) KCI등재후보
    2011-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2010-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2008-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.76 0.76 0.66
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.72 0.6 0.878 0.16
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼